Compare Stocks: BWAY, ESTA, INSP, and NVCR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BWAY Brainsway	$13.21 -1.8%	$14.83	$7.14 ▼ $17.40	$548.03M	1.25	81,699 shs	65,795 shs
ESTA Establishment Labs	$65.58 -3.2%	$78.36	$37.37 ▼ $97.59	$2.09B	1.05	304,401 shs	372,277 shs
INSP Inspire Medical Systems	$68.91 -0.2%	$61.14	$38.91 ▼ $147.03	$2.06B	0.7	768,286 shs	580,634 shs
NVCR NovoCure	$16.20 -0.3%	$16.79	$9.82 ▼ $21.45	$1.94B	1.01	1.01 million shs	1.14 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BWAY Brainsway	-1.78%	-2.37%	-8.45%	-8.77%	+77.20%
ESTA Establishment Labs	-3.22%	-5.72%	-9.11%	-25.80%	+57.42%
INSP Inspire Medical Systems	-0.23%	-5.46%	+12.54%	+50.96%	-11.46%
NVCR NovoCure	-0.31%	-3.11%	-8.06%	+4.99%	+26.17%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BWAY Brainsway	$13.21 -1.8%	$14.83	$7.14 ▼ $17.40	$548.03M	1.25	81,699 shs	65,795 shs
ESTA Establishment Labs	$65.58 -3.2%	$78.36	$37.37 ▼ $97.59	$2.09B	1.05	304,401 shs	372,277 shs
INSP Inspire Medical Systems	$68.91 -0.2%	$61.14	$38.91 ▼ $147.03	$2.06B	0.7	768,286 shs	580,634 shs
NVCR NovoCure	$16.20 -0.3%	$16.79	$9.82 ▼ $21.45	$1.94B	1.01	1.01 million shs	1.14 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BWAY Brainsway	-1.78%	-2.37%	-8.45%	-8.77%	+77.20%
ESTA Establishment Labs	-3.22%	-5.72%	-9.11%	-25.80%	+57.42%
INSP Inspire Medical Systems	-0.23%	-5.46%	+12.54%	+50.96%	-11.46%
NVCR NovoCure	-0.31%	-3.11%	-8.06%	+4.99%	+26.17%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BWAY Brainsway	2.71	Moderate Buy	$18.20	37.77% Upside
ESTA Establishment Labs	2.78	Moderate Buy	$100.25	52.87% Upside
INSP Inspire Medical Systems	2.11	Hold	$66.50	-3.49% Downside
NVCR NovoCure	2.14	Hold	$21.20	30.86% Upside

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, INSP, and NVCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/22/2026	INSP Inspire Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
9/22/2026	INSP Inspire Medical Systems	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/21/2026	ESTA Establishment Labs	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	INSP Inspire Medical Systems	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$75.00 ➝ $80.00
9/10/2026	BWAY Brainsway	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$20.00
9/8/2026	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
9/4/2026	INSP Inspire Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
9/1/2026	ESTA Establishment Labs	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$103.00
8/31/2026	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$17.00 ➝ $19.00
8/27/2026	NVCR NovoCure	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/19/2026	BWAY Brainsway	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)

(Data available from 9/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BWAY Brainsway	$52.22M	10.17	$0.23 per share	58.22	$1.87 per share	7.06
ESTA Establishment Labs	$211.08M	9.26	N/A	N/A	$0.81 per share	80.96
INSP Inspire Medical Systems	$911.98M	2.18	$2.77 per share	24.90	$26.88 per share	2.56
NVCR NovoCure	$655.35M	2.88	N/A	N/A	$3.04 per share	5.33

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BWAY Brainsway	$7.57M	$0.44	30.02	23.18	N/A	15.65%	12.74%	8.17%	11/10/2026 (Estimated)
ESTA Establishment Labs	-$51.06M	-$1.31	N/A	6,558.00	N/A	-15.82%	-196.69%	-10.73%	11/4/2026 (Estimated)
INSP Inspire Medical Systems	$145.42M	$4.62	14.91	44.46	5.39	15.03%	8.64%	7.45%	11/2/2026 (Estimated)
NVCR NovoCure	-$136.23M	-$1.30	N/A	N/A	N/A	-21.25%	-44.00%	-15.85%	10/29/2026 (Estimated)

Latest BWAY, ESTA, INSP, and NVCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	BWAY Brainsway	$0.10	$0.14	+$0.04	$0.07	$16.54 million	$17.11 million
8/6/2026	Q2 2026	ESTA Establishment Labs	-$0.3368	-$0.39	-$0.0532	-$0.39	$65.79 million	$67.54 million
8/3/2026	Q2 2026	INSP Inspire Medical Systems	-$0.2359	$0.14	+$0.3759	$0.01	$194.72 million	$200.58 million
7/23/2026	Q2 2026	NVCR NovoCure	-$0.3315	-$0.13	+$0.2015	-$0.13	$172.44 million	$183.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BWAY Brainsway	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
NVCR NovoCure	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BWAY Brainsway	N/A	3.59	3.27
ESTA Establishment Labs	12.11	3.84	2.52
INSP Inspire Medical Systems	N/A	8.55	6.16
NVCR NovoCure	0.58	2.89	2.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BWAY Brainsway	30.11%
ESTA Establishment Labs	72.91%
INSP Inspire Medical Systems	94.91%
NVCR NovoCure	84.61%

Insider Ownership

Company	Insider Ownership
BWAY Brainsway	19.00%
ESTA Establishment Labs	9.99%
INSP Inspire Medical Systems	2.20%
NVCR NovoCure	6.55%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BWAY Brainsway	129	40.21 million	32.57 million	Not Optionable
ESTA Establishment Labs	1,004	29.80 million	26.83 million	Optionable
INSP Inspire Medical Systems	1,333	28.91 million	28.27 million	Optionable
NVCR NovoCure	1,605	116.45 million	108.82 million	Optionable

BWAY, ESTA, INSP, and NVCR Headlines

Recent News About These Companies

NovoCure stock reports 15.6 percent Q2 revenue growth

September 24 at 10:19 PM | ad-hoc-news.deA

NovoCure (NASDAQ:NVCR) versus Carlsmed (NASDAQ:CARL) Financial Analysis

September 24 at 5:58 AM | americanbankingnews.com

NovoCure (NVCR) Stock Still Looks Cheap After Its 86% Fall

September 23 at 8:39 PM | finance.yahoo.com

NovoCure (NVCR) Could Be 36% Undervalued Despite Its Recent Board Change

September 23 at 10:37 AM | finance.yahoo.com

NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Hold" by Analysts

September 22 at 2:28 AM | americanbankingnews.com

NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Hold" from Analysts

September 22 at 2:28 AM | marketbeat.com

NovoCure Limited $NVCR Shares Sold by Engineers Gate Manager LP

September 19, 2026 | marketbeat.com

NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even

September 18, 2026 | marketbeat.com

NovoCure (NASDAQ:NVCR) Share Price Crosses Above Fifty Day Moving Average - What's Next?

September 18, 2026 | marketbeat.com

NovoCure Limited (NVCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 14, 2026 | seekingalpha.com

Allianz Asset Management GmbH Purchases New Position in NovoCure Limited $NVCR

September 10, 2026 | marketbeat.com

NovoCure Announces Routine Board Transition After Director Retirement

September 9, 2026 | tipranks.com

NovoCure (NASDAQ:NVCR) Trading Down 7.5% - Here's What Happened

September 8, 2026 | marketbeat.com

Novocure Reports Patient Data Exposure in Cybersecurity Incident

September 7, 2026 | zacks.com

Novocure says data exposed in cybersecurity incident

September 4, 2026 | massdevice.com

NovoCure Limited $NVCR Holdings Reduced by Bank of America Corp DE

September 3, 2026 | marketbeat.com

Cybersecurity breach at Novocure raises alarm after exposure of confidential patient data

September 2, 2026 | ciso.economictimes.indiatimes.com

Novocure data breach affects more than 1,400 cancer patients

September 2, 2026 | bleepingcomputer.comB

NovoCure drops as customer information leaked in cyberattack

September 1, 2026 | msn.com

Oncology firm Novocure says cyberattack exposed US patient records

September 1, 2026 | reuters.com

NovoCure (NASDAQ:NVCR) Rating Lowered to "Hold" at Wall Street Zen

August 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BWAY, ESTA, INSP, and NVCR Company Descriptions

Brainsway NASDAQ:BWAY

$13.21 -0.24 (-1.78%)

Closing price 09/24/2026 04:00 PM Eastern

Extended Trading

$13.35 +0.14 (+1.03%)

As of 05:01 AM Eastern

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Establishment Labs NASDAQ:ESTA

$65.58 -2.18 (-3.22%)

Closing price 09/24/2026 04:00 PM Eastern

Extended Trading

$65.60 +0.02 (+0.03%)

As of 04:09 AM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Inspire Medical Systems NYSE:INSP

$68.91 -0.15 (-0.22%)

Closing price 09/24/2026 03:59 PM Eastern

Extended Trading

$68.50 -0.41 (-0.59%)

As of 05:52 AM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

NovoCure NASDAQ:NVCR

$16.20 -0.05 (-0.31%)

Closing price 09/24/2026 04:00 PM Eastern

Extended Trading

$16.19 -0.01 (-0.06%)

As of 06:10 AM Eastern

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, INSP, and NVCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BWAY, ESTA, INSP, and NVCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BWAY, ESTA, INSP, and NVCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BWAY, ESTA, INSP, and NVCR Company Descriptions

Brainsway NASDAQ:BWAY

Establishment Labs NASDAQ:ESTA

Inspire Medical Systems NYSE:INSP

NovoCure NASDAQ:NVCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, INSP, and NVCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BWAY, ESTA, INSP, and NVCR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BWAY, ESTA, INSP, and NVCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BWAY, ESTA, INSP, and NVCR Company Descriptions

Brainsway NASDAQ:BWAY

Establishment Labs NASDAQ:ESTA

Inspire Medical Systems NYSE:INSP

NovoCure NASDAQ:NVCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools